TELETRADER News
3/13, 2:57 PM (Source: TeleTrader)
more TeleTrader news

J&J, BIDMC working together on COVID-19 vaccine

Johnson & Johnson announced on Friday it started collaborating with Beth Israel Deaconess Medical Center (BIDMC) to expedite the development of a COVID-19 vaccine.

The pharmaceutical giant said it hopes to start the phase 1 clinical study of a potential vaccine candidate by the end of the year. At the same time, the company will be preparing to upscale production and manufacturing capacities to levels required to meet global public health vaccination needs.

"It is critical to work with the best scientific minds as we look to rapidly identify and develop solutions to the COVID-19 outbreak," the company's chief scientific officer Paul Stoffels said. "By mobilizing our collective resources, we believe we can leverage the top science and cutting-edge capabilities to respond to this pandemic," he added.

Breaking the News / MD